Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS OIG Targets Medicare DME Costs In 2013 Work Plan

This article was originally published in The Gray Sheet

Executive Summary

The Office of Inspector General’s fiscal 2013 work plan outlines new projects to monitor costly overpayments for Medicare durable medical equipment and realize additional cost savings in the Medicaid program.

You may also be interested in...



Reimbursement Briefs: AMA Wants ICD-10 Halt; News From CMS, AHRQ And OIG

AMA asks CMS to reconsider ICD-10 implementation. CMS explores specialist payment models. AHRQ quality measures clearinghouse endorses new Medicare hip and knee replacement measures tied to readmissions and complications. More reimbursement news.

HHS OIG Expects Almost $4 Billion In Recoveries From First Half Of Fiscal 2013

Its spring 2013 Semiannual Report to Congress says the Office of Inspector General expects recoveries of about $3.8 billion from audits and investigations undertaken in the first half of fiscal year 2013, among other findings.

CMS In Brief

CMS announces 8.5% improper payment rate for FY 2012. HHS Office of Inspector General expects $6.9 billion in recoveries from audits and investigations. More CMS news.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031687

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel